134 related articles for article (PubMed ID: 11688968)
1. Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model.
Burke D; Carnochan P; Glover C; Allen-Mersh TG
Clin Exp Metastasis; 2000; 18(7):617-22. PubMed ID: 11688968
[TBL] [Abstract][Full Text] [Related]
2. Effect of regional angiotensin II infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastasis animal model.
Dworkin MJ; Zweit J; Carnochan P; Deehan B; Allen-Mersh TG
Eur J Cancer; 1996 Aug; 32A(9):1580-4. PubMed ID: 8911121
[TBL] [Abstract][Full Text] [Related]
3. Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases.
Shankar A; Loizidou M; Burnstock G; Taylor I
Br J Surg; 1999 Apr; 86(4):453-7. PubMed ID: 10215813
[TBL] [Abstract][Full Text] [Related]
4. Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients.
Gupta N; Saleem A; Kötz B; Osman S; Aboagye EO; Phillips R; Vernon C; Wasan H; Jones T; Hoskin PJ; Price PM
Clin Cancer Res; 2006 May; 12(10):3115-23. PubMed ID: 16707610
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.
Kissel J; Brix G; Bellemann ME; Strauss LG; Dimitrakopoulou-Strauss A; Port R; Haberkorn U; Lorenz WJ
Cancer Res; 1997 Aug; 57(16):3415-23. PubMed ID: 9270007
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin selectively increases 5-fluorouracil uptake by colorectal liver metastases following hepatic artery bolus infusion.
Dietz DW; Casillas S; Jones SC; Milsom JW
J Surg Res; 1998 Jul; 77(2):150-6. PubMed ID: 9733602
[TBL] [Abstract][Full Text] [Related]
7. Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
Dimitrakopoulou-Strauss A; Strauss LG; Schlag P; Hohenberger P; Irngartinger G; Oberdorfer F; Doll J; van Kaick G
J Nucl Med; 1998 Mar; 39(3):465-73. PubMed ID: 9529293
[TBL] [Abstract][Full Text] [Related]
8. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
Moehler M; Dimitrakopoulou-Strauss A; Gutzler F; Raeth U; Strauss LG; Stremmel W
Cancer; 1998 Jul; 83(2):245-53. PubMed ID: 9669806
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor infusion increases tumour vascularity, blood flow and chemotherapy uptake.
Davies MM; Burke D; Carnochan P; Glover C; Kaur S; Allen-Mersh TG
Acta Oncol; 2002; 41(1):84-90. PubMed ID: 11990524
[TBL] [Abstract][Full Text] [Related]
10. Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery. an autoradiographic study in the rat.
Mahteme H; Larsson B; Sundin A; Khamis H; Graf W
Eur J Cancer; 2004 Jan; 40(1):142-7. PubMed ID: 14687798
[TBL] [Abstract][Full Text] [Related]
11. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model.
Sadahiro S; Suzuki T; Ishikawa K; Tanaka Y; Masuda T; Nakamura T; Yasuda S; Makuuchi H; Murayama C
Jpn J Clin Oncol; 2003 Aug; 33(8):377-81. PubMed ID: 14523056
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma.
Dimitrakopoulou-Strauss A; Strauss LG; Schlag P; Hohenberger P; Möhler M; Oberdorfer F; van Kaick G
J Nucl Med; 1998 Jul; 39(7):1197-202. PubMed ID: 9669393
[TBL] [Abstract][Full Text] [Related]
14. Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model.
Flowerdew AD; Richards HK; Taylor I
Gut; 1987 Oct; 28(10):1201-7. PubMed ID: 3678948
[TBL] [Abstract][Full Text] [Related]
15. Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II.
Hemingway DM; Angerson WJ; Anderson JH; Goldberg JA; McArdle CS; Cooke TG
Br J Cancer; 1992 Nov; 66(5):958-60. PubMed ID: 1419643
[TBL] [Abstract][Full Text] [Related]
16. Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa.
Harte RJ; Matthews JC; O'Reilly SM; Tilsley DW; Osman S; Brown G; Luthra SJ; Brady F; Jones T; Price PM
J Clin Oncol; 1999 May; 17(5):1580-8. PubMed ID: 10334547
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
18. Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma.
Dimitrakopoulou A; Strauss LG; Clorius JH; Ostertag H; Schlag P; Heim M; Oberdorfer F; Helus F; Haberkorn U; van Kaick G
J Nucl Med; 1993 Jul; 34(7):1075-81. PubMed ID: 8315481
[TBL] [Abstract][Full Text] [Related]
19. 5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat.
Mahteme H; Larsson BS; Sundin A; Graf W
Anticancer Res; 1998; 18(2A):943-9. PubMed ID: 9615745
[TBL] [Abstract][Full Text] [Related]
20. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
